ARROWHEAD PHARMACEUTICALS, INC. Purchase Obligation, to be Paid, Year One
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Purchase Obligation, to be Paid, Year One of $60.20 million as of 2020-09-30, per its 10-K filed 2020-11-23.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2020-11-23
- 2020-09-30: Purchase Obligation, to be Paid, Year One $60.20M.
- 2019-09-30: Purchase Obligation, to be Paid, Year One $50.90M.
- 2018-09-30: Purchase Obligation, to be Paid, Year One $20.10M.
- 2015-09-30: Purchase Obligation, to be Paid, Year One $35.50M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2020-09-30 | $60.20M 10-K · filed 2020-11-23 |
| 2019-09-30 | $50.90M 10-K · filed 2019-11-25 |
| 2018-09-30 | $20.10M 10-K · filed 2018-12-11 |
| 2015-09-30 | $35.50M 10-K · filed 2015-12-14 |
| 2015-06-30 | $38.00M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $20.20M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $31.60M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $19.50M 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |